Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
91,200,454
-
Share change
-
-4,039,446
-
Total reported value
-
$8,874,238,168
-
Put/Call ratio
-
73%
-
Price per share
-
$97.32
-
Number of holders
-
394
-
Value change
-
-$391,326,180
-
Number of buys
-
203
-
Number of sells
-
177
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2021
As of 30 Jun 2021 NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) had 394 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 91,200,454 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, Bellevue Group AG, Bank of New York Mellon Corp, PICTET ASSET MANAGEMENT LTD, and DSM Capital Partners LLC.
This table shows 400 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.